On 14 November 2025, researchers at ETH Zurich announced in Science a major breakthrough: microrobots small enough to swim through blood vessels and deliver drugs precisely where needed — for example, to dissolve blood clots causing strokes. These “non-human workers” consist of spherical gel capsules, less than 2 mm in diameter, embedded with iron-oxide nanoparticles. The magnetic particles let doctors steer and control them remotely using external magnetic fields.
Once injected into the bloodstream or cerebrospinal fluid via a catheter, the microrobot is guided through the body’s vessels using a sophisticated navigation system. The researchers combined three magnetic-navigation strategies:
Once the microrobot reaches its target — say a thrombus (blood clot) in the brain — a high-frequency magnetic field heats the capsule, dissolving the gel shell and releasing the therapeutic agent precisely where it’s needed.
In laboratory tests, the team first used silicone vessel models that closely mimic real human and animal arteries to perfect their navigation strategy. Then they moved on to large-animal experiments:
Right now, human trials haven’t begun — but the results so far suggest these tiny agents could transform how we treat strokes, brain tumors, or other localized diseases, by massively cutting side effects.
This research could revolutionize targeted therapy. Today, to dissolve a stroke-related clot, we administer powerful drugs systemically — which affects the whole body and risks serious side effects like internal bleeding. By contrast, these microrobots act like AI employees in the body: they are guided, deliver their “task” (the drug), then disband. Because they are so precise, they could allow for lower dosages and fewer risks.
In a broader sense, this is part of a wave of medicine evolving to rely on non-human workers, or “voice AI agents,” in which external control systems direct microscopic devices inside us — opening doors to ultra-precise therapy, fewer side effects, and entirely new treatment approaches.
Key Highlights:
Reference: